Background: Antibiograms are stewardship tools that provide antimicrobial resistance data for regional bacterial isolates to guide treatment of infections.
| INTRODUCTION
Empirical antimicrobial treatment often is required to manage urinary tract infections (UTI) in veterinary patients, specifically for infections diagnosed by urinalysis or pending the results of culture and antimicrobial susceptibility testing. Making an educated antimicrobial choice to guide early treatment can decrease discomfort and minimize risk of ascending infection. Empirical treatment can be aided by urine sediment findings, prior history of UTI and response to treatment, knowledge of veterinary uropathogens, understanding of antimicrobial pharmacokinetics and pharmacodynamics, and review of consensus statements. Using evidence-based medicine to choose an antimicrobial likely to be effective the first time not only benefits the patient but also achieves overall stewardship goals of improving appropriate antimicrobial prescribing. 1 Antibiograms are a stewardship tool, both in human and veterinary medicine, to provide clinicians with updated information on local resistance patterns for bacterial isolates to help guide and improve successful treatment of various infections. 2, 3 In veterinary medicine, antimicrobial guideline statements, such as those available for UTIs, respiratory disease, and pyoderma, clarify that regional differences in susceptibility should be considered by veterinarians when deciding on the most appropriate antimicrobial protocol for a particular patient. [4] [5] [6] [7] Our objectives were to create antibiograms of urinary Escherichia coli isolates recovered from cats and dogs at the Kansas State Veterinary Diagnostic Laboratory from 2013 to 2017. These antibiograms then would be available as a regional stewardship tool to help guide evidence-based decisions on empirical treatment for UTIs for veterinary patients.
| MATERIALS AND METHODS
Ours was a retrospective review of aerobic urine culture results of cats and dogs from the Kansas State Veterinary Diagnostic Laboratory between 2013 and 2017. Diagnostic results were used to create antibiograms for E. coli urinary isolates from cats and dogs according to Clinical and Laboratory Standards Institutes (CLSI) guidelines. 2 
Feline and canine urine samples originating from both the Kansas State University
Veterinary Health Center and regional midwestern private veterinary practices were eligible for inclusion in the study. Any feline and canine urine sample from which E. coli was isolated was included in the study, Urine specimen handling before arrival at the laboratory was not standardized, but urine samples were plated within 4 hours of arrival.
Culture, isolation, and identification procedures were conducted according to laboratory standard-operating procedure at the time of specimen submission but varied slightly over the course of this retrospective analysis. All urine specimens initially were plated on trypticase soy (with 5% sheep blood) agar and MacConkey agar using a 10 μL calibrated loop. Cultures were incubated overnight (18-24 hours) at 37 C in 5% CO 2 . Individual colonies with phenotypic appearance for any uropathogen were streaked for isolation onto nonselective agar, and isolates were identified using 1 of 2 automated systems. From January 2013 to June 2013, isolates were identified using the Omnilog system was applied to the population of isolates from cats in our study, the percentage of isolates from cats reported susceptible would increase from 0 to 89% for AMP, and from 0 to 99% for AMC. The data set for our study did not delineate isolates from cases of subclinical bacteriuria versus clinical UTI, nor from azotemic versus non-azotemic cats;
thus, these results might not apply to each of these populations of cats similarly. Ideally, unique antibiograms would be created for each of these populations to allow clinicians to make the most appropriate conclusions and therapeutic decisions.
A study comparing susceptibility of E. coli UTI isolates from cats and dogs throughout Europe had very similar findings to ours, with 0% susceptibility to AMC among isolates from cats, with an MIC 90 of 8 μg/mL, when using the same breakpoint of S ≤ 0.25 μg/mL. 12 In that study, however, the breakpoint for ampicillin used was the breakpoint from dogs (S ≤ 8 μg/mL), thus they found 81.3% susceptibility despite MIC 90 >32 μg/mL. 12 This highlights the importance of noting the exact breakpoint used when reviewing susceptibility data, the challenges of comparing antibiograms and susceptibility results among studies, and the need for universal feline-specific UTI breakpoints.
It was also noteworthy that among the urinary E. coli isolates from dogs in our study, susceptibility to ampicillin (53%) was decreased compared with AMC (92%). This finding could suggest to regional veterinarians that AMC might be a better empirical choice than amoxicillin for treatment of E. coli UTIs in dogs. Although a regional finding, it emphasizes the need for evidence-based research to determine whether a benefit might exist for treating UTIs in dogs with AMC rather than amoxicillin alone. 4, 5 For comparison, in the study from Europe, 79% of E. coli UTI isolates from dogs were susceptible to AMP, whereas 98%
were susceptible to AMC. 12 The potential confounding effect of prior antimicrobial treatment should be taken into consideration when interpreting these results and making treatment decisions for future canine patients. Decisions for empirical treatment ideally would be made based on regional antibiograms from patients having received no prior antimicrobial treatment. Without these historical data, it is unclear to what extent ampicillin resistance seen in isolates from dogs in our study was influenced by previous beta-lactam exposure. This population could have been skewed with a higher proportion of isolates from cats and dogs with a history of beta-lactam antimicrobial use or of those having received multiple antimicrobial courses leading to greater resistance, because aerobic urine cultures might have been submitted more often in animals with recurrent UTI or previous therapeutic failure.
Our study also was limited by its retrospective nature which did not allow for consistent handling of urine samples before submission or for consistent time between urine collection and plating, because 
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